Showing 1 posts of 1 posts found.
Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO